PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
64.66%
Net income growth at 50-75% of BTE's 105.21%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-16.67%
Both reduce yoy D&A, with BTE at -90.34%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-156.97%
Both reduce yoy usage, with BTE at -179.87%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-156.97%
Both reduce yoy usage, with BTE at -179.87%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
115.40%
Well above BTE's 5.03%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-57.57%
Both yoy CFO lines are negative, with BTE at -59.03%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
24.93%
Some CapEx rise while BTE is negative at -200.21%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-133.05%
We reduce yoy other investing while BTE is 281.57%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-5.79%
We reduce yoy invests while BTE stands at 345.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
174.82%
Issuance growth of 174.82% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.